The production process of extract and fraction of Tropaeolum majus L. with a standardized concentration of markers and use of extract and fraction.

摘要

The production process of extract and fraction of Tropaeolum majus L. with a standardized concentration of markers and use of extract and fraction.The present invention patent is part of the process of obtaining a standardized extract (HETM) and the fraction enriched (TMLR) with diuretic, hypotensive and antihypertensive activity, to be used in kidney diseases and heart diseases, from tiropaeolum majus L.For that, it uses the aerial part of the plant, resulting in standardized extract that is distinguished by containing defined quantities of Isoquercitrin and reproducible marker.In addition, the invention discloses a pharmaceutical formulation contains a pharmacologically effective amount of the extract standardized with potential use for the treatment of hypertension and other kidney diseases causing edema. This pharmaceutical form is characterized by containing known amounts of Isoquercitrin and reproducible marker.